Organ, Tissue, and Cellular Deterioration in Disease: A Hierarchical View

Disease disrupts biological organization at every level—from organs down to extracellular matrix.

1. Organ‑Level Deterioration

  • Liver: Cirrhosis (alcohol, viral hepatitis, NASH) → architecture loss, synthetic failure, portal hypertension.
  • Heart: Ischemic cardiomyopathy, dilated cardiomyopathy → pump failure, arrhythmia.
  • Lungs: COPD, fibrosis → gas exchange impairment, pulmonary hypertension.
  • Kidneys: CKD → filtration decline, electrolyte/acid‑base dysregulation, anemia.

2. Tissue‑Level Deterioration

  • Muscle: Muscular dystrophy (dystrophin loss), sarcopenia, denervation atrophy.
  • Nervous: Alzheimer’s (amyloid/tau), Parkinson’s (α‑synuclein), MS (demyelination), stroke (infarction).
  • Connective: Rheumatoid arthritis (synovial pannus), lupus (immune complex deposition), scleroderma (fibrosis).

3. Cellular‑Level Deterioration

  • Red Blood Cells: Hemolysis (sickle cell, malaria, autoimmune), dysplasia (MDS).
  • White Blood Cells: Leukemia (clonal proliferation), lymphoma, immunodeficiency.
  • Epithelial: Carcinoma (mutations in TP53, KRAS, EGFR), metaplasia (Barrett’s).

4. Extracellular Matrix (ECM) Deterioration

  • Composition: Collagen, elastin, proteoglycans, glycoproteins.
  • Cancer: MMPs degrade ECM → invasion, metastasis.
  • Connective Tissue Disorders: Inflammation → collagen cross‑linking defects (Ehlers‑Danlos, Marfan).
  • Aging: Collagen ↓, elastin fragmentation → wrinkles, vascular stiffening, reduced tissue compliance.

These levels interact: cellular dysfunction → tissue failure → organ insufficiency → systemic disease. Therapeutic targets exist at each tier.

Bones, Joints & Muscles - Related Articles